Dr. Kaustuv BHATTACHARYA,
Metabolic Paediatrician, Genetic Metabolic Disorders Service, The Children’s Hospital at Westmead
Dr Kaustuv Bhattacharya is a UK trained metabolic physician. He moved to Sydney, Australia in June 2008 and became the department head of metabolic services at Sydney Children’s Hospitals Network in 2017. He is hon Senior Lecturer at Sydney University. He has strongly advocated and published in metabolic disease therapeutic research and clinical infrastructure and welcomes delegates to ICIEM in Australia.
Anita INWOOD, Ba Nurs, Grad Dip Paeds, MNP
Director, Queensland Lifespan Metabolic Medicine Service, Queensland Children’s Hospital, Brisbane, Australia
Associate lecturer, University of Queensland, Brisbane Australia
Anita Inwood has been a paediatric nurse for 30 years and working as the Queensland nurse lead in metabolic medicine for the previous 17yrs. She qualified as a Metabolic Nurse Practitioner (NP) through the University of Queensland in 2015 and a university associate lecturer since 2016. She was an executive committee member of the Australasian Society of Inborn Errors of Metabolism (ASIEM) from 2005 to 2019, during this time she held the positions of clinical nurse rep, secretary and chairperson. Anita won a Churchill Fellowship in 2012 and gained the opportunity to work in the United Kingdom with a focus on lysosomal storage disease and transition. Based on that experience she led the formation of the Queensland Lifespan Metabolic Medicine Service. Anita’s clinical responsibility is the management of children with phenylketonuria, fatty acid oxidation disorders and other causes of hypoglycaemia. In January 2020, Anita was appointed the Director of the Queensland Lifespan Metabolic Medicine Service.
Dr. Michel Tchan (BMedSc, MBBS, PhD, FRACP)
Adult Clinical Genetics & Genetic Metabolic Disorders
Dr. Tchan is a clinical and metabolic geneticist looking after adults with genetic disorders and inborn errors of metabolism. He is currently the Head of Department, Genetic Medicine at Westmead Hospital in Sydney, and a senior lecturer at the University of Sydney.
He is currently responsible for the NSW Adult Genetic Metabolic Disorders Clinic. His research interests include clinical aspects of the lysosomal storage disorders, the neurological consequences of phenylketonuria in adults, and clinical trials of novel therapies for genetic disorders.
Associate Professor Carolyn Ellaway (MBBS, PhD, FRACP, CGHGSA)
Genetic Metabolic Disorders Service, Sydney Children’s Hospital Network,
Disciplines of Child and Adolescent Health and Genomic Medicine
University of Sydney, Sydney Australia
Carolyn Ellaway has been working as a Pediatrician and Clinical Metabolic Geneticist with the Genetic Metabolic Disorders Service, Children’s Hospital, Westmead since 2001 and Sydney Children’s Hospital, Randwick, since 2014. She is the Head of the NSW Genetic Metabolic Disorders Service. Carolyn is a Clinical Associate Professor at the University of Sydney.
In her clinical role, Carolyn has been responsible for the care of children with a wide range of genetic metabolic disorders, this has included the multidisciplinary treatment of patients with lysosomal storage disorders and enzyme replacement therapy (ERT) delivery.
Associate Professor Ellaway obtained her medical degree from the University of Melbourne in 1990, before completing her PhD at Sydney University in 2001. She has published over 80 journal articles and 4 book chapters. She has been invited to speak at local and international conferences, and is an investigator of several clinical trials.
Dr. Kevin Carpenter (FFSc(RCPA), FHGSA)
Chief Executive Officer, Human Genetics Society of Australasia
Kevin Carpenter trained in Clinical Chemistry in Sheffield in the UK. He obtained an MSc from the University of Leeds and entered the field of inborn errors of metabolism at Sheffield Children’s Hospital in the mid-1980s. He completed a PhD with University of Sheffield in 1996.
He worked at the NSW Biochemical Genetics Service from 1994 and was appointed Head of Department in 2003. In 2017 he joined the Australasian Association for Clinical Biochemistry and Laboratory Medicine in the role of CEO and, since 2018 has the same role with the Human Genetics Society of Australasia.